期刊文献+

卵巢卵黄囊瘤临床病理分析 被引量:4

Clinicopathological analysis of ovarian yolk sac tumor
下载PDF
导出
摘要 目的观察与研讨卵巢卵黄囊瘤(YST)患者临床病理、诊治方式及预后情况。方法回顾分析两院1998~2012年收治的41例卵巢YST患者临床资料。结果典型与混合型病例临床比例均明显高于其他类型(P〈0.05),典型与混合型病例比例差异无统计学意义(P〉0.05);术后随访发现:临床处于I期与Ⅱ期患者均健在的有13、10例;2例均为混合型I期患者手术3年后死亡;3例临床处于Ⅱ期患者手术2年后死亡,其中有2例为混合型;临床8例Ⅲ期患者术后仅存活1年为2例,其余6例存活未超过2年;临床Ⅳ期5例患者术后存活均未超过3个月。结论临床多取材并进行全面观测的方式有利于对卵巢YST的确诊,手术治疗与化疗结合可提升患者的存活率。 Objective To observe and discuss the ovarian yolk sac tumor (YST) clinical pathology, diagnosis and treatment methods and prognosis. Methods Retrospective analysis of clinical data of patients with ovarian YST in our hospital. Results The typical clinical cases with mixed ratio were significantly higher than other types (P 〈 0. 05 ), the typical proportion of cases with mixed significant difference ( P 〉 0. 05 ) ; postoperative follow-up found that: in clinical stage I and II patients were there 13,10 patients alive; 2 cases were mixed stage I patients died after surgery three years; 3 cases in stage I1 clinical surgery two years after the death of patients, including two cases of mixed type ; clinical 8 stage I1 patients after only two cases sur- vived one year, and the remaining six cases survived less than 2 years; clinical 5 stage 1V were patients survived for more than three months. Conclusion The clinical observations and more comprehensive coverage and the way is beneficial for the diagnosis of ovarian YST, surgery combined with chemotherapy can improve the pa- tient' s survival.
出处 《中国现代药物应用》 2014年第1期7-8,共2页 Chinese Journal of Modern Drug Application
关键词 卵巢YST 生殖细胞 化疗 Ovarian YST Germ cell Chemotherapy
  • 相关文献

参考文献5

二级参考文献20

  • 1田扬顺,马向东,王红英,黄高升,李学荣.卵巢卵黄囊瘤27例临床与病理分析[J].陕西医学杂志,2006,35(1):102-104. 被引量:4
  • 2SICARI M C,FYFE B,PAMESS I,et al.Intrapericardiac yolk sac tumor associated with acute myocarditis[J].Arch Pathol Lab Med,1999,123(3):241-243.
  • 3NOGALES F F.Embryologic clues to human yolk sac tumors.A review[J].J Gynecol Pathol,1993,12:101-107.
  • 4KURMAN R J,NORRIS H J.Endodermal sinus tumor of the ovary.A clinical and pathologic analysis of 71 cases[J].Canser,1976,38(6):2404-2419.
  • 5KAWAI M,FURUHASHI Y,KANO T,et al.Alphafetoprotein in malignant germ cell tumors of the ovary[J].Gynecol Oncol,1990,39(2):160-166.
  • 6GERSHENSON D M,DEL JUNCO G,HERSON J,et al.Endodermal sinus tumor of the ovary.The M.D.Anderson experience[J].Obstet Genecol,1983,61(2):194-202.
  • 7Kawai M,Kano T,Furuhashi Y,et al.Prognostic factors in yoljk sac tumors of the ovary:a clinicalpathological analysis of 29 cases[J].Cancer,1991,167(1):184-192.
  • 8Nawa A,Obata N,Kikawa F,et al.Prognostic factors of petients with yoljk sac tumors of the ovary[J].Am J Obstet Gynecol,2001,184(6):1182-1188.
  • 9Gallion H,Nagell JR,Powell DF,et al.Therapy of endodermal sinus tumor of the ovary[J].Am J Obstet Gynecol,1979,135(4):194-202.
  • 10Slayton RE,Park RC,Silverberg SG,et al.Vincristin,dactinomycin,and cyclophosphamide in the tretment of malignant germ cell tumors of the ovray.A Gynecologic Oncology Group Study[J].Cancer,1985,56(2):243-248.

共引文献11

同被引文献4

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部